Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?
{{output}}
Introduction: The combination of MEK and BRAF inhibitors is effective in melanomas and other tumors with BRAF V600E mutations. MEK inhibitors enhance efficacy and delay the development of resistance to BRAF inhibitors. Recently, ... ...
